Search results

Learn the potential advantages and disadvantages of fundraising with SAFE agreements and everything you need to know before issuing SAFEs.

Carta's AI release briefing: Rearchitecting private capital operations. Discover new LLM Plugins and AI tools for data automation.

In recent quarters, seed-stage software valuations have been booming in San Francisco and New York. As a result, the gap between these two traditional startup hubs and the rest of the U.S. has been getting wider.

Discover real-time insights on round sizes, valuations, and dilution with Carta's Round Benchmarking Tool. Tailor benchmarks by stage, sector, and region.

In the midst of a relatively stagnant fundraising environment, emerging fund managers may have an appealing value proposition to present to LPs.

PE firms typically don't invest in the sort of high-growth startups that dominate the AI market today. But that doesn't mean PE is sitting out the AI revolution.

What auditors look for, where companies go wrong, and how to build defensible infrastructure before it matters most.

Everything you need to know about zero exercise price options, including how ZEPOs work, tax benefits, and how you can leverage it as part of your ESS.

When institutional investors enter the conversation, the diligence bar is materially higher than most founders expect. Here’s what they scrutinize across your financials, cap table, and R&D claims—and how to stay ahead before that first conversation.

Venture capital is making a comeback, with $30.4 billion raised in Q1 2026, fewer down rounds and less dilution. However, over 60% of funding went to AI, creating a huge valuation gap for startups.

Pre-seed startup funding in Q1 2026 matches recent quarters, suggesting a stabilization of the market.